Snowball logo
logo
GYRE

Gyre Therapeutics Inc.

GYRE NASDAQ
$7.39+$0.15  (2.07%)

Frequently asked questions

What sector does Gyre Therapeutics Inc. (GYRE) operate in?

Gyre Therapeutics Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Gyre Therapeutics Inc. (GYRE) current stock price?

As of the latest data, Gyre Therapeutics Inc. stock price is $7.39, with a previous close of $7.24. Gyre Therapeutics Inc. gained $0.15 in the last trading session, representing a 2.07% increase.

What is Gyre Therapeutics Inc. (GYRE) current market capitalization?

Gyre Therapeutics Inc. market cap is approximately 674.81 million.

What is Gyre Therapeutics Inc. (GYRE) Earnings Per Share (EPS)?

The trailing EPS is $0.02, and the forward EPS is -$0.20.

What is Gyre Therapeutics Inc. (GYRE) Price-to-Earnings (P/E) ratio?

Gyre Therapeutics Inc. current P/E ratio is 369.5.

What is Gyre Therapeutics Inc. (GYRE) EBITDA?

Gyre Therapeutics Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 815.00 thousand.

Does Gyre Therapeutics Inc. (GYRE) pay dividends?

No. Gyre Therapeutics Inc. does not pay a dividend.

How did Gyre Therapeutics Inc. (GYRE) perform in its most recent earnings report?

In the last report (December 31, 2025), Gyre Therapeutics Inc. posted an EPS surprise of 0.21% and a revenue surprise of -67.61%.

When is Gyre Therapeutics Inc. (GYRE) next earnings report?

Gyre Therapeutics Inc. is expected to release its next earnings report on March 31, 2026.

What is Gyre Therapeutics Inc. (GYRE) beta (volatility) score?

Gyre Therapeutics Inc. has a beta of 6.399, indicating very high volatility compared to the market.